Patents
Patents for C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
12/2005
12/15/2005WO2005117883A1 Modulators of muscarinic receptors
12/15/2005WO2005097768A3 Novel gamma secretase inhibitors
12/15/2005CA2568524A1 Modulators of muscarinic receptors
12/14/2005EP1496902B1 Medicament containing steroids and a novel anticholinergic drug
12/14/2005CN1708493A Selected CGRP antagonists, method for production and use thereof as medicament
12/14/2005CN1231483C 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives
12/14/2005CN1231480C 1,2,3-thiadiazole carboxylic acid (thio) esters and use thereof as pest control agent or as microbicide
12/14/2005CN1231467C High affinity ligands for nociceptin receptor ORL-1
12/08/2005WO2005117242A1 Method and installation means for installing an electrical machine
12/08/2005WO2005115361A2 Androgen receptor modulators and method of treating disease using the same
12/08/2005WO2005077932A3 Chemokine receptor antagonists
12/08/2005US20050272753 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide
12/08/2005CA2566942A1 Androgen receptor modulators and method of treating disease using the same
12/07/2005EP1307449B1 1,4-dihydropyridines as bradykinin antagonists
12/06/2005USRE38912 for treating a number of complaints, particularly respiratory diseases
12/06/2005CA2354606C Azabicycloalkane derivatives and therapeutic uses thereof
12/01/2005WO2005077899A3 Amino-substituted tricyclic derivatives and methods of use
11/2005
11/30/2005EP1599472A1 Ccr-3 receptor antagonists
11/30/2005CN1703412A Novel compounds with antibacterial activity
11/30/2005CN1229375C Nicotinic acetylcholine receptor inhibitor, its prepn. and application
11/24/2005US20050261496 3-(Morpholin-4-ylsulfonyl)-5-(1,3-thiazol-2-yl)-1H-indole-2-carboxamide; inhibiting, modulating and/or regulating signal transduction of both receptor and non-receptor tyrosine kinases; anticarcinogenic, -diabetic, -arhtritic, -inflammatory agents; psoriasis; angiogenesisinhibitors; liver cirrhosis
11/16/2005EP1594874A1 Novel 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/16/2005EP1594868A1 8-aza-bicyclo (3.2.1) octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/15/2005US6964972 8-Azabicyclo(3,2,1)oct-2 ene and octane derivatives as cholinergic ligands at nicotinic ACh receptors
11/10/2005WO2005105770A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/10/2005WO2005105089A1 Remedy for psychoneurotic diseases
11/10/2005US20050250808 Each compound having an azabicyclic ring attached via a ring N or amino group; neuroprotectants; neurodegenerative diseases, analgesics, psychological disorders; e.g. 5-Methoxy-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxamide; ligands for nicotinic acetylcholine receptors
11/10/2005US20050250792 Substituted piperidine compounds useful as modulators of chemokine receptor activity
11/10/2005US20050250763 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
11/10/2005US20050250730 Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
11/10/2005CA2562176A1 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/09/2005CN1694704A Use of (1H-benzimidazole-2-yl)-(piperazineyl)- ketaderavitive and correlative compound used as histamine H4 receptor antagonist for the treatment of allergy and asthma
11/03/2005WO2005103054A2 Bridged piperazine and piperidine derivatives as ccri antagonists
11/03/2005WO2005103033A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
11/03/2005WO2005103002A2 Novel alkyne compounds with an mch-antagonistic action and medicaments comprising said compounds
11/03/2005DE102004018796A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments
11/03/2005DE102004017934A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them
11/03/2005CA2562100A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
11/03/2005CA2559917A1 Compounds as ccri antagonists
11/03/2005CA2559688A1 Novel alkyne compounds with an mch-antagonistic action and medicaments comprising said compounds
11/02/2005EP1590338A2 Modulators of melanocortin receptor
11/02/2005EP1590007A1 Improved radiometal complex compositions
11/02/2005EP1589968A2 Quaternary antimuscarinic compounds for the treatment of bladder diseases
11/01/2005US6960666 administering an azabicyclo or azatricyclo compound to treat inflammatory diseases such as asthma
10/2005
10/27/2005WO2005100352A1 Selected cgrp-antagonists, their preparation processes and their use as medicaments
10/27/2005WO2005100350A1 Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
10/27/2005WO2005100343A1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs
10/27/2005WO2005099706A2 Muscarinic acetylcholine receptor antagonists
10/27/2005WO2005099698A1 STABILIZED 4-AMINO-5-CHLORO-N-[(1R,3r,5S)-8-METHYL-8- AZABICYCLO[3.2.1]OCT-3-YL]-2-[1-METHYLBUT-2-YNYLOXY]-BENZAMIDE CONTAINING COMPOSITION
10/27/2005WO2005073228A8 Method for producing a 2-(ethoxymethyl)tropane derivative
10/27/2005US20050239824 Triple monoamine reuptake inhibitors for the treatment of chronic pain
10/27/2005DE102004018795A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments
10/27/2005CA2563386A1 Selected cgrp-antagonists, their preparation processes and their use as medicaments
10/27/2005CA2562526A1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs
10/26/2005CN1687062A Compound N-2-methylsulfonyl ethyl group-2 beta-carbo methoxy group-3-beta-(4-chlorphenyl) nortropane, and synthetic method
10/26/2005CN1224389C The use of scopolamine salts
10/25/2005CA2238170C Process for the production of endotropine
10/20/2005WO2005097768A2 Novel gamma secretase inhibitors
10/20/2005WO2005097738A1 Novel sulfonamide derivative
10/20/2005US20050234101 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
10/20/2005CA2563033A1 Novel gamma secretase inhibitors
10/19/2005EP1586574A1 Medicaments containing betamimetic drugs and a novel anticholinesterase drug
10/19/2005CN1684961A Methods for producing hydroxyalkyl tropane esters
10/13/2005WO2005095380A1 Cyclic amine compound and pest control agent
10/13/2005WO2005095353A1 Tetrahydro-indazole cannabinoid modulators
10/13/2005WO2005021536A3 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors
10/13/2005US20050228034 treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease; for treating, ameliorating or preventing a CB1 receptor inverse-agonist mediated appetite related obesity related or metabolism related syndrome, disorder or disease
10/13/2005US20050228014 Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
10/13/2005CA2561305A1 Tetrahydro-indazole cannabinoid modulators
10/12/2005CN1680371A Tropan derivatives useful in therapy, method for obtaining thereof and intermediate compounds
10/05/2005EP1581530A1 Indane compounds as ccr5 antagonists
10/05/2005EP1581309A2 Kinase modulators
10/05/2005CN1678591A New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
10/05/2005CN1221549C Crystalline monohydrate, method for producing the same and the use thereof in the production of medicament
10/04/2005US6951849 Psychological disorders; central nervous system disorders; schizophrenia
09/2005
09/29/2005WO2005090350A1 Substituted piperidine compounds and methods of their use
09/29/2005DE102004013227A1 Production of 3-beta-aminonortropane derivatives, useful as e.g. N-methyl-D-aspartate receptor modulators, or synthetic intermediates, comprises preparing an imine, converting the imine into a stable tautomer or isomer, and hydrolyzing
09/29/2005DE102004012070A1 Neue cycloalkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel New cycloalkyl-containing 5-Acylindolinone, their preparation and their use as medicaments
09/28/2005EP1578747A2 Novel herbicides
09/27/2005US6949583 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method of preparing same and compositions containing same
09/27/2005US6949573 Substituted 3-amidopyridine derivatives are useful for treating inflammatory, allergic and respiratory diseases, as well as wounds
09/27/2005CA2079814C Cationic lipids for intracellular delivery of biologically active molecules
09/22/2005WO2005087761A1 Novel cycloalkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
09/22/2005US20050209185 Synergistic mixture; administering by inhalation; tiotropium bromide; metered dose inhaler, a dry powder inhaler; asthma, chronic obstructive pulmonary disease
09/22/2005CA2559143A1 Novel cycloalkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
09/21/2005CN1671684A Novel benzodioxoles
09/21/2005CN1219780C Heterocyclic compounds binding chemotactic factor receptor
09/15/2005WO2005085228A1 Cycloalkanopyridine derivative
09/15/2005WO2005085200A1 Pyridone derivative
09/15/2005US20050203123 Substituted piperidine compounds and methods of their use
09/15/2005US20050203104 Cycloalkyl - containing 5-acylindolinones, the preparation thereof and their use as medicaments
09/15/2005CA2558274A1 Cycloalkanopyridine derivative
09/14/2005EP1572668A2 N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
09/14/2005EP1572207A1 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines
09/14/2005EP1461318B1 Tetrahydroquinoline analogues as muscarinic agonists
09/14/2005CN1668614A Bicyclic piperidine derivatives as antagonists of the CCR1 chemokine receptor
09/08/2005US20050197363 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
09/08/2005US20050197360 3-Beta-(p-Chlorophenyl)-2-beta-(3-(p-methylphenyl)-oxazol-5-yl)-tropane or a salt, especially the HCl salt; useful as substitute drugs for psychostimulant abuse and as neurotransmitter re-uptake inhibitors; for treating Parkinson's Disease, depression, and eating, bipolar, sexual, and AD disorders
09/08/2005US20050197357 Anticholinergics which may be used as medicaments as well as processes for preparing them
09/08/2005US20050197335 Indazole-carboxamide compounds as 5-HT4 receptor agonists
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 53